KRYS compared with ARWR: revenue, margins and what each company keeps, and the suppliers and customers both name

KRYSKrystal Biotech, Inc.

Mkt capRevenueRevenue

ARWRArrowhead Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

KRYSKrystal Biotech, Inc.

ARWRArrowhead Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

KRYS

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±8.7%▼−10.95%×1.25

Q2 FY26±10.1%▼−8.37%×0.83

Q1 FY26±8.1%▲+4.12%×0.51

Jan 12 '26±3.8%▲+4.10%×1.08

ARWR

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±8.5%▼−2.99%×0.35

Q2 FY26±7.3%▼−6.75%×0.93

= impliedKRYS realized, solidARWR realized, hatchedOne scale, both sides: full bar = 24%× = |realized| ÷ impliedSource: market data

Q1 FY26

±11.4%

▼−0.19%

×0.02

Nov 26 '25±13.6%▲+23.34%×1.71

KRYSKrystal Biotech, Inc.

299.22▲+1.12%

Mkt cap$8.8BRevenue$127MQ3 FY26Revenue$389MFY25

ARWRArrowhead Pharmaceuticals, Inc.

60.32▲+1.26%

Regular sessionNov 3 '26

Mkt cap$8.5BRevenue$75MQ3 FY26Revenue$829MFY25

Compare

Regular sessionNov 3 '26

KRYSKrystal Biotech, Inc.

ARWRArrowhead Pharmaceuticals, Inc.

299.22▲+1.12%

Price

60.32▲+1.26%

$8.8B

Mkt cap

$8.5B

Q3 FY26$127M

Revenue

$75MQ3 FY26

FY25$389M

Revenue

$829MFY25

KRYS299.22▲+1.12%vsARWR60.32▲+1.26%Regular sessionNov 3 '26